Siemens Healthineers (OTCMKTS:SMMNY) Issues Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Siemens Healthineers (OTCMKTS:SMMNY) announced its quarterly earnings data on Thursday. The company reported $0.31 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.02, Zacks reports. The firm had revenue of $6.68 billion during the quarter, compared to analysts’ expectations of $6.96 billion.

Siemens Healthineers Stock Performance

Shares of OTCMKTS:SMMNY traded down $0.07 on Friday, hitting $19.84. The company’s stock had a trading volume of 147,758 shares, compared to its average volume of 169,811. The company has a 50-day simple moving average of $21.90 and a 200 day simple moving average of $24.41. Siemens Healthineers has a 1 year low of $19.54 and a 1 year high of $28.92.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the stock. Sanford C. Bernstein raised shares of Siemens Healthineers to a “strong-buy” rating in a research report on Tuesday, January 13th. Zacks Research upgraded Siemens Healthineers from a “strong sell” rating to a “hold” rating in a research report on Monday, January 12th. Finally, Citigroup reiterated a “buy” rating on shares of Siemens Healthineers in a research report on Friday, January 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy”.

Siemens Healthineers Company Profile

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.